Physician profile
Andrew Son
NPI 1154684702
$3,098.07
in general payments reported to CMS, 2019-2025
10 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $228 · 2021: $356 · 2022: $306 · 2023: $557 · 2024: $753 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,585.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,455.27 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic Vascular, INC. | $560.76 | 2019-2020 | |
| Medtronic, INC. | $287.10 | 2021-2025 | Endurant Iis, In.Pact Admiral |
| Bard Peripheral Vascular, INC. | $270.73 | 2020-2021 | |
| Boston Scientific Corporation | $196.23 | 2019-2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Smith+Nephew, INC. | $156.28 | 2019-2020 | |
| Becton, Dickinson and Company | $99.66 | 2024 | Lutonix Drug Coated Balloon |
| Inspiremd LTD | $25.20 | 2025 | Cguard Prime Carotid Stent System |
| Tactile Systems Technology INC | $24.35 | 2024 | Flexitouch Plus, Entre Plus |
| Stryker Corporation | $22.49 | 2025 | Artix Mt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Son listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.